drugset / Trial / NCT04594070

Daily Versus Alternate Day Iron Supplementation for the Treatment of Iron Deficiency Anemia in Pregnancy

NCT04594070

Phase 4 Terminated 14 enrolled The University of Texas Medical Branch, Galveston
RandomizedParallel-groupOpen-labelTreatment

Summary

The target population for our study is pregnant women in the first or second trimester with a diagnosis of iron deficiency anemia. If a subject is eligible, written consent will be obtained by person to person contact. Eligible participants will be randomized to receive either daily oral iron supplementation or every other day oral iron supplementation.

Timeline

Start
2020-10-27
Primary completion
2024-01-12
Completion
2024-01-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ferrous Sulfate Diagnostic / imaging agent 325 mg Oral
Subject Ferrous Sulfate Diagnostic / imaging agent 650 mg Oral